These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 34427065)

  • 21. Convalescent plasma treatment of critically ill intensive care COVID-19 patients.
    Lindemann M; Lenz V; Knop D; Klump H; Alt M; Aufderhorst UW; Schipper L; Schwarzkopf S; Meller L; Steckel N; Koldehoff M; Heinold A; Heinemann FM; Fischer J; Hutschenreuter G; Knabbe C; Dolff S; Brenner T; Dittmer U; Witzke O; Herbstreit F; Horn PA; Krawczyk A
    Transfusion; 2021 May; 61(5):1394-1403. PubMed ID: 33784412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Convalescent plasma associates with reduced mortality and improved clinical trajectory in patients hospitalized with COVID-19.
    Arnold Egloff SA; Junglen A; Restivo JS; Wongskhaluang M; Martin C; Doshi P; Schlauch D; Fromell G; Sears LE; Correll M; Burris HA; LeMaistre CF
    J Clin Invest; 2021 Oct; 131(20):. PubMed ID: 34464352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of convalescent plasma therapy in severely and critically ill patients with COVID-19: a systematic review with meta-analysis.
    Wenjing L; Yuanzheng F; Li JY; Tang LV; Yu H
    Aging (Albany NY); 2020 Dec; 13(1):1498-1509. PubMed ID: 33323550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of convalescent plasma transfusion for the treatment of severely ill COVID-19 patients in Pakistan.
    Khan TNS; Mukry SN; Masood S; Meraj L; Devrajani BR; Akram J; Fatima N; Maqsood S; Mahesar A; Siddiqui R; Ishaque S; Afzal MB; Mukhtar S; Ahmed S; Naz A; Shamsi TS
    BMC Infect Dis; 2021 Sep; 21(1):1014. PubMed ID: 34579646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks.
    Wooding DJ; Bach H
    Clin Microbiol Infect; 2020 Oct; 26(10):1436-1446. PubMed ID: 32791241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Convalescent plasma - Is it useful for treating SARS Co-V2 infection?
    Ranganathan S; Iyer RN
    Indian J Med Microbiol; 2020; 38(3 & 4):252-260. PubMed ID: 33154232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Convalescent plasma as an adjunctive therapy for COVID-19: A single centre experience in Malaysia.
    Lee KT; Yeoh WC; Zainul NH; Syed Alwi SB; Low LL
    Med J Malaysia; 2021 Sep; 76(5):653-657. PubMed ID: 34508370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Administration of high titer convalescent anti-SARS-CoV-2 plasma: From donor selection to monitoring recipient outcomes.
    Mendoza RP; Fyke W; Daniel D; Gabutan E; Das B; Bajaj H; Easy M; Vasileva A; Colbourn R; Alawad M; Dehghani A; Lin B; Emechebe D; Patel P; Jabbar A; Nikolov DB; Giovaniello D; Kang S; Tatem L; Bromberg K; Augenbraun M; Premsrirut P; Libien J; Norin AJ
    Hum Immunol; 2021 Apr; 82(4):255-263. PubMed ID: 33640208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of convalescent plasma versus standard of care for the treatment of COVID-19 in hospitalized patients: study protocol for a phase 2 randomized, open-label, controlled, multicenter trial.
    Diago-Sempere E; Bueno JL; Sancho-López A; Rubio EM; Torres F; de Molina RM; Fernández-Cruz A; de Diego IS; Velasco-Iglesias A; Payares-Herrera C; Flecha IC; Avendaño-Solà C; Palomino RD; Ramos-Martínez A; Ruiz-Antorán B
    Trials; 2021 Jan; 22(1):70. PubMed ID: 33472681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of convalescent plasma therapy in severe COVID-19 patients.
    Duan K; Liu B; Li C; Zhang H; Yu T; Qu J; Zhou M; Chen L; Meng S; Hu Y; Peng C; Yuan M; Huang J; Wang Z; Yu J; Gao X; Wang D; Yu X; Li L; Zhang J; Wu X; Li B; Xu Y; Chen W; Peng Y; Hu Y; Lin L; Liu X; Huang S; Zhou Z; Zhang L; Wang Y; Zhang Z; Deng K; Xia Z; Gong Q; Zhang W; Zheng X; Liu Y; Yang H; Zhou D; Yu D; Hou J; Shi Z; Chen S; Chen Z; Zhang X; Yang X
    Proc Natl Acad Sci U S A; 2020 Apr; 117(17):9490-9496. PubMed ID: 32253318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
    Piechotta V; Iannizzi C; Chai KL; Valk SJ; Kimber C; Dorando E; Monsef I; Wood EM; Lamikanra AA; Roberts DJ; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013600. PubMed ID: 34013969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.
    Janssen M; Schäkel U; Djuka Fokou C; Krisam J; Stermann J; Kriegsmann K; Haberbosch I; Novotny JP; Weber S; Vehreschild M; Bornhäuser M; Bullinger L; Schmitt M; Liebregts T; Dreger P; Lorenz HM; Plaszczyca A; Bartenschlager R; Müller B; Kräusslich HG; Halama N; Jäger D; Schlenk RF; Leo A; Meuer S; Weigand MA; Motsch J; Merle U; Denkinger CM; Müller-Tidow C
    Trials; 2020 Oct; 21(1):828. PubMed ID: 33023671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Successful administration of convalescent plasma in critically ill COVID-19 patients in Hungary: the first two cases].
    Bobek I; Gopcsa L; Réti M; Bekő G; Hancz L; Lakatos B; Molnár E; Nagy S; Reményi P; Sebestyén G; Sinkó J; Szlávik J; Szolnoky M; Vályi-Nagy I
    Orv Hetil; 2020 Jul; 161(27):1111-1121. PubMed ID: 32564002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outpatient convalescent plasma therapy for high-risk patients with early COVID-19: a randomized placebo-controlled trial.
    Gharbharan A; Jordans C; Zwaginga L; Papageorgiou G; van Geloven N; van Wijngaarden P; den Hollander J; Karim F; van Leeuwen-Segarceanu E; Soetekouw R; Lammers J; Postma D; Kampschreur L; Groeneveld G; Swaneveld F; van der Schoot CE; Götz H; Haagmans B; Koopmans M; Bogers S; Geurtsvankessel C; Zwaginga JJ; Rokx C; Rijnders B;
    Clin Microbiol Infect; 2023 Feb; 29(2):208-214. PubMed ID: 36007870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study.
    Liu STH; Lin HM; Baine I; Wajnberg A; Gumprecht JP; Rahman F; Rodriguez D; Tandon P; Bassily-Marcus A; Bander J; Sanky C; Dupper A; Zheng A; Nguyen FT; Amanat F; Stadlbauer D; Altman DR; Chen BK; Krammer F; Mendu DR; Firpo-Betancourt A; Levin MA; Bagiella E; Casadevall A; Cordon-Cardo C; Jhang JS; Arinsburg SA; Reich DL; Aberg JA; Bouvier NM
    Nat Med; 2020 Nov; 26(11):1708-1713. PubMed ID: 32934372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Convalescent Plasma Treatment in Patients with Covid-19: A Systematic Review and Meta-Analysis.
    Jorda A; Kussmann M; Kolenchery N; Siller-Matula JM; Zeitlinger M; Jilma B; Gelbenegger G
    Front Immunol; 2022; 13():817829. PubMed ID: 35197981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of convalescent plasma therapy in severe COVID-19 patients.
    Akay Cizmecioglu H; Goktepe MH; Demircioglu S; Tekinalp A; Cizmecioglu A; Tuna AK; Ozer H
    Transfus Apher Sci; 2021 Aug; 60(4):103158. PubMed ID: 33994106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy assessment of convalescent plasma therapy for COVID-19 patients: a multi-center case series.
    Zeng H; Wang D; Nie J; Liang H; Gu J; Zhao A; Xu L; Lang C; Cui X; Guo X; Zhou C; Li H; Guo B; Zhang J; Wang Q; Fang L; Liu W; Huang Y; Mao W; Chen Y; Zou Q
    Signal Transduct Target Ther; 2020 Oct; 5(1):219. PubMed ID: 33024082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Convalescent plasma for the treatment of patients with severe coronavirus disease 2019: A preliminary report.
    Omrani AS; Zaqout A; Baiou A; Daghfal J; Elkum N; Alattar RA; Bakdach D; Abusriwil H; Mostafa AM; Alhariri B; Ambra N; Khatib M; Eldeeb AM; Merenkov Z; Fawzi Z; Hmissi SM; Hssain AA; Coyle PV; Alsoub H; Almaslamani MA; Alkhal A
    J Med Virol; 2021 Mar; 93(3):1678-1686. PubMed ID: 32965715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Life-saving effect of convalescent plasma treatment in covid-19 disease: Clinical trial from eastern Anatolia.
    Erkurt MA; Sarici A; Berber İ; Kuku İ; Kaya E; Özgül M
    Transfus Apher Sci; 2020 Oct; 59(5):102867. PubMed ID: 32620409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.